The resistance of the IMA to atherosclerosis might be associated with its higher eNOS, ACE and ET-A receptor immunoreactivity.
Zulli
Anthony
A
Hare
David L
DL
Horrigan
Mark
M
Buxton
Brian F
BF
D001161:Arteriosclerosis / Q000209:etiology*; D001026:Coronary Artery Bypass; D004198:Disease Susceptibility; D004730:Endothelium, Vascular / Q000737:chemistry*; D006801:Humans; D008323:Mammary Arteries / Q000737:chemistry*; D019001:Nitric Oxide Synthase / Q000032:analysis*; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A / Q000032:analysis*; D044022:Receptor, Endothelin A / Q000032:analysis*
D044022:Receptor, Endothelin A; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D007703:Peptidyl-Dipeptidase A